Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response

References

• HanafiahKMGroegerJFlaxmanADWiersmaSTGlobal epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalenceHepatology20135741333134223172780
   PubMed Web of Science ®Google Scholar
• El-SeragHBEpidemiology of viral hepatitis and hepatocellular carcinomaGastroenterology2012142612641273.e122537432
   PubMed Web of Science ®Google Scholar
• PoynardTYuenMFRatziuVLaiCLViral hepatitis CLancet200336294012095210014697814
   PubMed Web of Science ®Google Scholar
• RazaviHWakedISarrazinCThe present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigmJ Viral Hepat201421Suppl 1345924713005
   PubMed Web of Science ®Google Scholar
• FattovichGGiustinaGDegosFMorbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patientsGastroenterology199711224634729024300
   PubMed Web of Science ®Google Scholar
• OmlandLHKrarupHJepsenPMortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort studyJ Hepatol2010531364220400197
   PubMed Web of Science ®Google Scholar
• SeeffLBNatural history of chronic hepatitis CHepatology2002365 Suppl 1S35S4612407575
   PubMed Web of Science ®Google Scholar
• SangiovanniAPratiGMFasaniPThe natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patientsHepatology20064361303131016729298
   PubMed Web of Science ®Google Scholar
• BenvegnuLNatural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsGut200453574474915082595
   PubMed Web of Science ®Google Scholar
• AlemanSRahbinNWeilandOA risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosisClin Infect Dis201357223023623616492
   PubMed Web of Science ®Google Scholar
• HedenstiernaMNangarhariAWeilandOAlemanSDiabetes and cirrhosis are risk factors for hepatocellular carcinoma after successful treatment of chronic hepatitis CClin Infect Dis Off Publ Infect Dis Soc Am2016636723729
   Web of Science ®Google Scholar
• van der MeerAJVeldtBJFeldJJAssociation between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisJAMA2012308242584259323268517
   PubMed Web of Science ®Google Scholar
• VeldtBJChenWHeathcoteEJIncreased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitusHepatology20084761856186218506898
   PubMed Web of Science ®Google Scholar
• ElkriefLChouinardPBenderskyNDiabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis CHepatology201460382383124841704
   PubMed Web of Science ®Google Scholar
• ChristensenPBClausenMRKrarupHLaursenALSchlichtingPWeisNTreatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection: Danish national guidelines 2011Dan Med J2012596C446522677253
   PubMed Web of Science ®Google Scholar
• European Association for Study of LiverEASL recommendations on treatment of hepatitis C 2015J Hepatol201563119923625911336
   PubMed Web of Science ®Google Scholar
• HansenNObelNChristensenPBPredictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort studyJ Viral Hepat200916965966519486467
   PubMed Web of Science ®Google Scholar
• PedersenCBThe Danish Civil Registration SystemScand J Public Health2011397 Suppl222521775345
   PubMed Web of Science ®Google Scholar
• AndersenTFMadsenMJørgensenJMellemkjoerLOlsenJHThe Danish national hospital register: a valuable source of data for modern health sciencesDan Med Bull199946326326810421985
   PubMed Web of Science ®Google Scholar
• Patobank [website on the Internet]2017 Available from: http://www.patobank.dkAccessed November 9, 2015
   Google Scholar
• Helweg-LarsenKThe Danish register of causes of deathScand J Public Health2011397 Suppl2629
   PubMed Web of Science ®Google Scholar
• GjerstorffMLThe Danish cancer registryScand J Public Health2011397 Suppl424521775350
   PubMed Web of Science ®Google Scholar
• HallagerSChristensenPBLadelundSMortality in patients with chronic hepatitis C and cirrhosis compared to the general population: a Danish cohort studyJ Infect Dis2017215219220127803168
   PubMed Web of Science ®Google Scholar
• CôtéRARobboySProgress in medical information management: systematized nomenclature of medicine (SNOMED)JAMA198024387567626986000
   PubMed Web of Science ®Google Scholar
• BedossaPPoynardTAn algorithm for the grading of activity in chronic hepatitis C: the METAVIR cooperative study groupHepatology19962422892938690394
   PubMed Web of Science ®Google Scholar
• DegosFPerezPRocheBDiagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study)J Hepatol20105361013102120850886
   PubMed Web of Science ®Google Scholar
• ChristiansenKMMössnerBKHansenJFJarnbjerEFPedersenCChristensenPBLiver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective studyPloS One2014911e11191225369038
   PubMed Web of Science ®Google Scholar
• BoursierJZarskiJPde LedinghenVDetermination of reliability criteria for liver stiffness evaluation by transient elastographyHepatology20135731182119122899556
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care20051130113916224307
   PubMed Web of Science ®Google Scholar
• GannaAIngelssonE5 Year mortality predictors in 498,103 UK Biobank participants: a prospective population-based studyLancet2015386999353354026049253
   PubMed Web of Science ®Google Scholar
• Danish Health AuthorityAnbefalinger om alkohol2010 Available from: https://sundhedsstyrelsen.dk/da/sundhed-og-livsstil/alkohol/anbefalingerAccessed February 25, 2016
   Google Scholar
• RostgaardKMethods for stratification of person-time and events: a prerequisite for Poisson regression and SIR estimationEpidemiol Perspect Innov20085719014582
   PubMedGoogle Scholar
• FoundationRThe R project for statistical computing2017 Available from: https://www.r-project.orgAccessed January 21, 2016
   Google Scholar
• KanwalFKramerJRIlyasJDuanZEl-SeragHBHCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. veterans with HCVHepatology20146019810524615981
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL clinical practice guidelines: management of hepatitis C virus infectionJ Hepatol201155224526421371579
   PubMed Web of Science ®Google Scholar
• van der MeerAJFeldJJHoferHRisk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationJ Hepatol201766348549327780714
   PubMed Web of Science ®Google Scholar
• El-SeragHBKanwalFRichardsonPKramerJRisk of hepatocellular carcinoma after sustained virologic response in veterans with HCV-infection: HCC after SVR2016 Available from: https://dissem.in/p/80365084/risk-of-hepatocellular-carcinoma-after-sustained-virologic-response-in-veterans-with-hcv-infection-hcc-after-svrAccessed August 31, 2017
   Google Scholar
• RatziuVMunteanuMCharlotteFBonyhayLPoynardTFibrogenic impact of high serum glucose in chronic hepatitis CJ Hepatol20033961049105514642625
   PubMed Web of Science ®Google Scholar
• BochudPYCaiTOverbeckKGenotype 3 is associated with accelerated fibrosis progression in chronic hepatitis CJ Hepatol200951465566619665246
   PubMed Web of Science ®Google Scholar
• McMahonBJBrudenDTownshend-BulsonLInfection with hepatitis C virus genotype 3 is an independent risk factor for end-stage liver disease, hepatocellular carcinoma, and liver-related deathClin Gastroenterol Hepatol2017153431437.e227765729
   PubMed Web of Science ®Google Scholar
• BaffyGBruntEMCaldwellSHHepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menaceJ Hepatol20125661384139122326465
   PubMed Web of Science ®Google Scholar
• DavilaJAMorganROShaibYMcGlynnKAEl-SeragHBDiabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control studyGut200554453353915753540
   PubMed Web of Science ®Google Scholar
• AsselahTRubbia-BrandtLMarcellinPNegroFSteatosis in chronic hepatitis C: why does it really matter?Gut200655112313016344578
   PubMed Web of Science ®Google Scholar
• DegosFChristidisCGanne-CarrieNHepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and deathGut200047113113610861275
   PubMed Web of Science ®Google Scholar
• ThygesenSKChristiansenCFChristensenSLashTLSørensenHTThe predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish national registry of patientsBMC Med Res Methodol2011118321619668
   PubMed Web of Science ®Google Scholar
• NielsenGLSørensenHTPedersenABSabroeSAnalyses of data quality in registries concerning diabetes mellitus: a comparison between a population based hospital discharge and an insulin prescription registryJ Med Syst19962011108708487
   PubMedGoogle Scholar
• LokASSeeffLBMorganTRIncidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseGastroenterology2009136113814818848939
   PubMed Web of Science ®Google Scholar
• BrunoSStroffoliniTColomboMSustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: a retrospective studyHepatology200745357958717326216
   PubMed Web of Science ®Google Scholar
• CardosoACMoucariRFigueiredo-MendesCImpact of pegin-terferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosisJ Hepatol201052565265720346533
   PubMed Web of Science ®Google Scholar
• DienstagJLGhanyMGMorganTRA prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CHepatology201154239640521520194
   PubMed Web of Science ®Google Scholar
• European Association for Study of Liver, European Organisation for Research and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• SarasinFPGiostraEHadengueACost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosisAm J Med199610144224348873514
   PubMed Web of Science ®Google Scholar
• ChristensenPBHayGJepsenPHepatitis C prevalence in Den-mark: an estimate based on multiple national registersBMC Infect Dis201212122214291
   PubMed Web of Science ®Google Scholar
• TörnerAStokkelandKSvenssonAThe underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidenceHepatology201765388589227533761
   PubMed Web of Science ®Google Scholar